Like with Most in Precious Metals, Our Ideas are Performing Rather Well.
And we have a new name! Americore Resources (AMCOF) $0.54.
We got bullish on Gold back in 2019, when it first broke through an old high of $1,400. We got involved, but certainly not ‘bells’ deep. We were having way too much fun with the Biotech’s.
Is Gold ($1,330) About to Cross the Magic Five Year High of $1,400?
Around the same time, we watched (as in ‘our’ Watch List) Biotech companies like Immunomedics go from $3 to $87 in a buyout, Dicerna go from $3 to $38 in a buyout, and Provention Bio go from $4.60 to $25 in a buyout.
Immunomedics, Dicerna and Provention: And We Have a $26.4 Billion Winning Trifecta!
But when Gold touched $3,500, we said that’s it. We are going bells deep. This is what we want to do for the next three to five years – as we sail into our 70’s (age wise). In the following month, in May of 2025, we launched the Institutional Gold Analyst service and set the stage to host our first Gold Investor Conference.
We started adding names to the Watch List, aiming to have 20-25 names by the end of 2025. But then a little distraction called AI came along. That and Data Centers – which are near and dear to our hearts. And that sucked all of us into a vortex of distraction. So, we finished the year with only 6 names on the Watch List. But now, we’re back on track.
For now, some basics on Americore (AMCOF), an idea that comes from one of our many bird dogs, this one in Kansas City, of all places.
We’ll have a recap of all the names this weekend, a standalone report on Americore later in the week.
In addition, next week:
- Standalone Report on GeoVax (GOVX) related to MonkeyPox.
- Standalone Report on Society Pass (SOPA) related to their new M&A Strategy.
- Standalone Report on Sekur Private Data (SWISF) and its related Partnership with Quaestor Federal.
Americore Resources (AMCOF)
